Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study

Blood (2023) 142 (Supplement 1): 1538.

https://doi.org/10.1182/blood-2023-173092

Published: 2023

Journal Articles

Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study

Blood (2022) 140 (Supplement 1): 8919–8920.

https://doi.org/10.1182/blood-2022-162591

Published: 2022

Journal Articles

The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification

Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad H. Mattour, Mary Frances McMullin, Andrew Charles Perkins, Gabriela Rodríguez-Macias, Hassan Sibai, Qin Qin, Yan Sun, Jalaja Potluri, Jason Harb, Jonathan How

Blood (2022) 140 (Supplement 1): 583–585.

https://doi.org/10.1182/blood-2022-157949

Published: 2022

Journal Articles

Patients with Acute Myeloid Leukemia on Non-Intensive Therapy: Applicability of the European Leukemia Net Risk Classification

Pablo Silva, Jon Badiola, Reyes María Martín-Rojas, Ignacio Gómez-Centurión, Gabriela Rodríguez-Macias, Marina Gómez-Llobell, Carolina Martínez-Laperche, Diego Carbonell, Mónica Ballesteros, Ana Pérez-Corral, María Chicano, Patricia Font Lopez, Isabel Pérez-Sánchez, Ismael Buño, Javier Anguita, Mi Kwon, José Luis Díez-Martín

Blood (2021) 138 (Supplement 1): 3382.

https://doi.org/10.1182/blood-2021-153202

Published: 2021

Journal Articles

Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry

Blood (2021) 138 (Supplement 1): 1255.

https://doi.org/10.1182/blood-2021-150544

Published: 2021

Journal Articles

Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Blood (2021) 138 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2021-150649

Published: 2021

Journal Articles

Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia

Reyes María Martín-Rojas, Jon Badiola, Pablo Silva De Tena, Ana Pérez-Corral, Ignacio Gómez-Centurión, Gabriela Rodríguez-Macias, Mónica Ballesteros, Carolina Martínez-Laperche, Patricia Font Lopez, Isabel Pérez-Sánchez, Ismael Buño, Javier Anguita, Mi Kwon, Jose L. Diez-Martin

Blood (2021) 138 (Supplement 1): 1287.

https://doi.org/10.1182/blood-2021-150808

Published: 2021

Journal Articles

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Pilar Martínez, MD, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, MD, Javier Cornago Navascués, MD, Gabriela Rodriguez-Macías, MD, Isabel Cano, MD, Montserrat Arnan Sangerman, María-Belén Vidriales, MDPhD, Jesús Lorenzo Algarra, Maria Angeles Foncillas, Pilar Herrera Puente, Carmen Botella, Susana Vives, MD, Angela Figuera Alvarez, MD PhD, Laida Cuevas Palomares, Marta Sobas, MDPhD, Alejandro Contento-Gonzalo, MD, Rebeca Cuello, MD, María Elena Amutio Diez, MD, Maria Dunia De Miguel, MD, Begoña Navas, MD, Juan Miguel Bergua Burgues, MD, Teresa Bernal del Castillo, MD PhD, María Carmen Mateos Rodríguez, MD, Erik de Cabo López, MD, Ana Carolina Franco Villegas, MD, Raimundo García-Boyero, MD, Cristian Escolano Escobar, MD, Cristina Seri, MD, Carlos Cervero, MD, Alicia Roldán Pérez, Maria Lourdes Hermosin, MD, Marta Cervera, MD, María Teresa Olave, MD, Paola Sandra Villafuerte Gutierrez, MD, Almudena De Laiglesia, MD, Josefina Serrano, MD, María Josefa Najera Irazu, MD, Jose Luis Piñana Sanchez, Miguel Ángel Sanz, MD, Joaquin Martinez-Lopez, MD, Pau Montesinos, MD PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-138471

Published: 2020

Journal Articles

Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-141213

Published: 2020

Journal Articles

Whole Exome Sequencing Reveals Acquisition of Mutations Leading to the Onset of Donor Cell Leukemia after Hematopoietic Transplantation. a Model of Leukemogenesis

Julia Suárez González, Carolina Martinez-Laperche, Nerea Martínez, Gabriela Rodriguez-Macías, Mi Kwon, MD, Pascual Balsalobre, David Serrano, MD, Miguel Angel A. Piris, Jorge Gayoso, MD, Jose Luis Díez Martín, Ismael Buño, PhD

Blood (2016) 128 (22): 2879.

https://doi.org/10.1182/blood.V128.22.2879.2879

Published: 2016

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

Juan Miguel Bergua, Pau Montesinos, MD, David Martinez-Cuadrón, MD, Pascual Fernández-Abellán, MD, Josefina Serrano, MD, María José Sayas, MD, Julio Prieto-Fernandez, MD, Raimundo Garcia, MD, Ana Julia Garcia-Huerta, MD, Manuel Barrios, MD, Cristina Pérez-López, MD, Manuel Perez-Encinas, MD, Adriana Siemele, MD, Gabriela Rodriguez-Macias, MD, Pilar Herrera-Puente, Rebeca Rodríguez-Veiga, MD, Maria Pilar Martinez-Sanchez, MD, Maria Lourdes Amador-Barciela, MD, Miguel A. Sanz, MD PhD

Blood (2014) 124 (21): 1049.

https://doi.org/10.1182/blood.V124.21.1049.1049

Published: 2014

Journal Articles

Inmune Reconstitution After Autologous Stem Cell Trasplantation: Is There Any Difference Between HIV+ and HIV- Patients?

Mariana Bastos Oreiro, Alicia Roldan, Javier Anguita, MD, Cristina Pascual, MD, Ana Perez, Pascual Balsalobre, MSc, Mi Kwon, Gabriela Rodriguez Macias, Jorge Gayoso, MD, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD

Blood (2012) 120 (21): 4665.

https://doi.org/10.1182/blood.V120.21.4665.4665

Published: 2012

Journal Articles

Role of Bcl-2 Immunohistochemical Expression As An Independent Biological Prognostic Marker At Diagnosis of Classical Hodgkin's Lymphoma

Leyre Bento, Gabriela Rodriguez Macias, Pascual Balsalobre, Jorge Gayoso, Isabel Gonzalez-Gascon y Marin, Cristina Muñoz-Martínez, Mi Kwon, David Serrano, Javier Menárguez, Jose Luis Diez Martin

Blood (2011) 118 (21): 4859.

https://doi.org/10.1182/blood.V118.21.4859.4859

Published: 2011

Journal Articles

Natural Killer (NK) Cell Reconstitution After Haploidentical Unmanipulated Bone Marrow Transplantation with Reduced Intensity Conditioning

Isabel Gonzalez-Gascon y Marin, Ana Maria Perez-Corral, Jorge Gayoso, Javier Anguita, Cristina Pascual, Mi Kwon, David Serrano, Gabriela Rodriguez-Macias, Pascual Balsalobre, Jose Luis Diez-Martin

Blood (2011) 118 (21): 4557.

https://doi.org/10.1182/blood.V118.21.4557.4557

Published: 2011

Journal Articles

Bcl2 Over-Expression as a Prognostic factor In Hodgkin Lymphoma Patients who Required Intensive Treatment

Gabriela Rodriguez-Macias, Jorge Gayoso, Leyre Bento, Isabel Gonzalez, Javier Menarguez, Pascual Balsalobre, Cristina Muñoz-Martinez, Patricia Font, Cristina Encinas, Santiago Osorio, Mi Kwon, David Serrano, Antonio Escudero, Jose Luis Diez-Martin

Blood (2010) 116 (21): 4825.

https://doi.org/10.1182/blood.V116.21.4825.4825

Published: 2010

Journal Articles

Dynamics of Chimerism In Regulatory T Lymphocytes (Treg; CD4+/CD25+) After Allogeneic Stem Cell Transplantation

Víctor Noriega, Carolina Martinez-Laperche, David Serrano, Gabriela Rodriguez-Macias, Mi Kwon, Jorge Gayoso, Pascual Balsalobre, Jose Luis Diez-Martin, Dr., Ismael Buno

Blood (2010) 116 (21): 1328.

https://doi.org/10.1182/blood.V116.21.1328.1328

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with High Risk Hematologic Malignancies

David Serrano, Rafael Carrión, Pilar Miralles, Gabriela Rodriguez-Macias, Jorge Gayoso, Juan Berenguer, Javier Anguita, Mi Kwon, Pascual Balsalobre, Gomez-Pineda Alfonso, Ismael Buno, Jose L. Diez-Martin

Blood (2008) 112 (11): 4387.

https://doi.org/10.1182/blood.V112.11.4387.4387

Published: 2008

Journal Articles

The Relative Percentage of Recipient T (CD3+) and Activated Lymphocytes (CD25+) Allows to Predict the Dynamics of Chimerism and the Risk of Complications after Allogeneic Stem Cell Transplantation

Ismael Buno Borde, PhD, Cintia Manzano, Pascual Balsalobre, David Serrano, MD, Gabriela Rodriguez Macias, MD, Alfonso Gomez-Pineda, MD, PhD, Jose L. Diez-Martin, MD, PhD

Blood (2008) 112 (11): 4362.

https://doi.org/10.1182/blood.V112.11.4362.4362

Published: 2008

Journal Articles

Methylation in the Promoter Region and Expression of FOX-P3 Correlate with Graft Versus Host Disease, Relapse and Survival after Allogeneic Stem Cell Transplantation

Cintia Manzano Gonzalez, Pascual Balsalobre, David Serrano, MD, Gabriela Rodriguez Macias, MD, Alfonso Gomez- Pineda, MD, PhD, Jose L. Diez-Martin, MD, PhD, Ismael Buno, PhD

Blood (2008) 112 (11): 1254.

https://doi.org/10.1182/blood.V112.11.1254.1254

Published: 2008

NARROW

Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study

Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study

The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification

Patients with Acute Myeloid Leukemia on Non-Intensive Therapy: Applicability of the European Leukemia Net Risk Classification

Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry

Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Whole Exome Sequencing Reveals Acquisition of Mutations Leading to the Onset of Donor Cell Leukemia after Hematopoietic Transplantation. a Model of Leukemogenesis

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

Inmune Reconstitution After Autologous Stem Cell Trasplantation: Is There Any Difference Between HIV+ and HIV- Patients?

Role of Bcl-2 Immunohistochemical Expression As An Independent Biological Prognostic Marker At Diagnosis of Classical Hodgkin's Lymphoma

Natural Killer (NK) Cell Reconstitution After Haploidentical Unmanipulated Bone Marrow Transplantation with Reduced Intensity Conditioning

Bcl2 Over-Expression as a Prognostic factor In Hodgkin Lymphoma Patients who Required Intensive Treatment

Dynamics of Chimerism In Regulatory T Lymphocytes (Treg; CD4+/CD25+) After Allogeneic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with High Risk Hematologic Malignancies

The Relative Percentage of Recipient T (CD3+) and Activated Lymphocytes (CD25+) Allows to Predict the Dynamics of Chimerism and the Risk of Complications after Allogeneic Stem Cell Transplantation

Methylation in the Promoter Region and Expression of FOX-P3 Correlate with Graft Versus Host Disease, Relapse and Survival after Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only